Search the GHTC website
August 29, 2019

GHTC sends FY21 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2021 (FY21) budget.

June 3, 2019

GHTC submits FY20 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY20) budget.

May 31, 2019

GHTC endorses Comprehensive TB Elimination Act

GHTC joined other advocates in endorsing the Comprehensive TB Elimination Act of 2019, which would enhance tuberculosis (TB) R&D at the National Institutes of Health and facilitate coordination of late stage R&D of new TB diagnostic, treatment, and prevention tools with the Biomedical Advanced Research and Development Authority.

May 24, 2019

GHTC statement on High-Level Meeting on Tuberculosis delivered at WHA

A statement by GHTC and partners calling on the World Health Organization and member states to close the US$1.3 billion gap in annual tuberculosis (TB) R&D funding was made at the 72nd World Health Assembly. The statement urges countries to invest in the development of new medicines and technologies to treat multidrug-resistant TB and to facilitate rapid and equitable access to these interventions.